longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Revvity

RVTY

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Revvity +15.4%, most brokers rate it buy

    Weekly Review·1 day ago, 06:40 AM
    RVTY-2.24%
  • Revvity Inc. Stock Underperforms Friday When Compared To Competitors

    MarketWatch Automated·2 days ago, 09:09 PM
    RVTY-2.24%
  • Revvity SVP Global Operations Tajinder S. Vohra sells 7,330 shares worth $1,032,650.40

    PUBT·2 days ago, 08:05 PM
    RVTY-2.24%
  • Here’s How Much You Would Have Made Owning Revvity Stock In The Last 15 Years

    benzinga_article·Sep 16 at 09:15 PM
    RVTY-2.24%
  • Skyworks Jumped, Coinbase and Bitcoin Dropped

    Baystreet·Sep 16 at 01:26 PM
    - Bitcoin fell by over 3% to close at around $75,600 after the U.S. Senate failed to advance the CLARITY crypto market structure bill. - Crypto-related equities, including Coinbase and Robinhood, traded sharply lower alongside a broader tech sector decline led by Nasdaq falling by 0.78%. - Skyworks Solutions gained 13.55% amid merger progress, while Revvity jumped by 9.11% to reach a new high of $140.19 following a healthcare conference presentation.
    HOOD+9.12%SWKS-2.80%
  • Biotech Stocks At 52-Week Highs - MNOV +8%, RVTY +8%, TXG +6%, TLX +9%, SDGR +12%

    rttnews·Sep 16 at 05:23 AM
    RVTY-2.24%TXG-0.48%
  • RVTY: Transformation drives growth, margin expansion, and digital leadership in life sciences

    Quartr·Sep 14 at 02:06 PM
    RVTY-2.24%
  • Revvity Inc. Stock Underperforms Thursday When Compared To Competitors

    MarketWatch Automated·Sep 10 at 09:13 PM
    RVTY-2.24%
  • Revvity (RVTY) Receives a New Rating from UBS

    Tip Ranks·Sep 9 at 10:47 AM
    RVTY-2.24%
  • Revvity agrees to acquire Human Cell Design in metabolic disease research push

    PUBT·Sep 9 at 10:00 AM
    RVTY-2.24%
  • Revvity Inc. Stock Underperforms Tuesday When Compared To Competitors

    MarketWatch Automated·Sep 8 at 09:13 PM
    RVTY-2.24%
  • Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

    MarketWatch Automated·Sep 2 at 09:11 PM
    RVTY-2.24%
  • Revvity (NYSE:RVTY) Sets New 52-Week High - Here's What Happened

    Market Beat·Sep 2 at 04:01 PM
    RVTY-2.24%